Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOX versus mFOLFOX6 as first-line treatment for metastatic colorectal cancer
ChiCTR-TRC-12002734Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tegafur, oxaliplatin, fluorouracil and folinic acid in colorectal cancer (CRC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Progression-free survival. Started Mar 2011; status: completed.
02
Drugs
tegafuroxaliplatinfluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR-TRC-12002734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002734.